A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells-Reference-Cited by-同舟云学术

A novel PAD4/SOX4/PU.1 signaling pathway is involved in the committed differentiation of acute promyelocytic leukemia cells into granulocytic cells

Published:2015-12-10 Issue:3 Volume:7 Page:3144-3157
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Song Guanhua¹,Shi Lulu¹,Guo Yuqi¹,Yu Linchang¹,Wang Lin²,Zhang Xiaoyu¹,Li Lianlian¹,Han Yang¹,Ren Xia¹,Guo Qiang¹,Bi Kehong³,Jiang Guosheng¹

Affiliation:

1. Department of Hemato-Oncology, Institute of Basic Medicine, Shandong Academy of Medical Sciences, Key Medical Laboratory for Tumor Immunology and Traditional Chinese Medicine Immunology of Shandong, Jinan, Shandong, China

2. Research Center for Medicinal Biotechnology, Shandong Academy of Medicinal Sciences, Jinan, Shandong, China

3. Qianfoshan Hospital of Shandong, Jinan, Shandong, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment;International Journal of Biological Macromolecules;2024-10

2. PADI4 negatively regulates RIG-I-mediated antiviral response through deacetylation of IFN-β promoter via HDAC1;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-04

3. Roles of PADI4 in the expression of cytokines involved in inflammation and adhesion in differentiated NB4 cells treated with ATRA;Experimental and Therapeutic Medicine;2023-01-31

4. SOX4 Mediates ATRA-Induced Differentiation in Neuroblastoma Cells;Cancers;2022-11-17

5. PAD4 and Its Inhibitors in Cancer Progression and Prognosis;Pharmaceutics;2022-11-08